ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis

Qu, Shanqiang; Qi, Songtao; Zhang, Huayang; Li, Zhiyong; Wang, Kaicheng; Zhu, Taichen; Ye, Rongxu; Zhang, Wanghao; Huang, Guanglong*; Yi, Guo-zhong*南方医科大学; 1
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH2023-10-28DOI: 10.1186/s13046-023-02843-6
1被引5阅读
引用收藏
分享

摘要

BackgroundTemozolomide (TMZ) treatment efficacy in glioblastoma (GBM) patients has been limited by resistance in the clinic. Currently, there are no clinically proven therapeutic options available to restore TMZ treatment sensitivity. Here, we investigated the potential of albumin-bound paclitaxel (ABX), a novel microtubule targeting agent, in sensitizing GBM cells to TMZ and elucidated its underlying molecular mechanism.MethodsA series of in vivo and in vitro experiments based on two GBM cell lines and two primary GBM cells were designed to evaluate the efficacy of ABX in sensitizing GBM cells to TMZ. Further proteomic analysis and validation experiments were performed to explore the underlying molecular mechanism. Finally, the efficacy and mechanism were validated in GBM patients derived organoids (PDOs) models.ResultsABX exhibited a synergistic inhibitory effect on GBM cells when combined with TMZ in vitro. Combination treatment of TMZ and ABX was highly effective in suppressing GBM progression and significantly prolonged the survival oforthotopic xenograft nude mice, with negligible side effects. Further proteomic analysis and experimental validation demonstrated that the combined treatment of ABX and TMZ can induce sustained DNA damage by disrupting XPC and ERCC1 expression and nuclear localization. Additionally, the combination treatment can enhance ferroptosis through regulating HOXM1 and GPX4 expression. Preclinical drug-sensitivity testing based on GBM PDOs models confirmed that combination therapy was significantly more effective than conventional TMZ monotherapy.ConclusionOur findings suggest that ABX has the potential to enhance TMZ treatment sensitivity in GBM, which provides a promising therapeutic strategy for GBM patients.

学科与关键词

关键词
GlioblastomaTemozolomide sensitivityAlbumin-bound paclitaxelDNA damage repairFerroptosis
相关
加载中…
  • Prrx1 promotes resistance to temozolomide by upregulating ABCC1 and inducing vasculogenic mimicry in glioma
    Chen, Zetao; Zhang, Yujie; Chen, Yihong; Lin, Wanmei; Zhang, Yuxuan; Cai, Guixing; Sun, Xinlin; Zheng, Kehong; He, Jie; Ai, Tianjing; Wang, Jihui*; Zhao, Liang*; Ke, Yiquan*American Journal of Cancer Research, 2022, 12(8): 3892-+.被引 2
  • Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
    Tang, Qingfa; Cao, Haihong; Tong, Ni; Liu, Yuanliang; Wang, Wanyu; Zou, Yuheng; Xu, Lanyang; Zeng, Zhiyun; Xu, Wei; Yin, Zhixin; Ma, Wenjuan*; Wang, Qirui*PHYTOMEDICINE, 2022, 99: 154016.被引 17
  • The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma
    Shi, Linyong; Chen, Hanning; Chen, Kunxiang; Zhong, Chengzong; Song, Chong; Huang, Yifeng; Wang, Tong; Chen, Lei; Li, Chiyang; Huang, Annie; Qi, Songtao; Li, Hong*; Lu, Yuntao*Clinical Cancer Research, 2023, 29(16): 3172-3188.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
发表日期
2023-10-28
卷期
第 42 卷, 第 1 期
页码
285
DOI
10.1186/s13046-023-02843-6
语言
ENGLISH
成果收录
SCIE
资助标注
We are grateful to Dr. Zexin Chen for providing the invaluable assistance provided in the GBM PDOs construction.

作者

  • Q

    Qu, Shanqiang (第一作者)

    southern med univ

  • Q

    Qi, Songtao

    southern med univ

查看全部 10 位作者收起作者
  • Z

    Zhang, Huayang

    southern med univ · 1

  • L

    Li, Zhiyong

    southern med univ

  • W

    Wang, Kaicheng

    southern med univ · 1

  • Z

    Zhu, Taichen

    1 · southern med univ

  • Y

    Ye, Rongxu

    southern med univ · 1

  • Z

    Zhang, Wanghao

    southern med univ · 1

  • H

    Huang, Guanglong (通讯)

    southern med univ

  • Y

    Yi, Guo-zhong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417